SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-053015
Filing Date
2008-09-22
Accepted
2008-09-22 19:34:20
Documents
1
Period of Report
2008-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4014
  Complete submission text file 0001209191-08-053015.txt   6011
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC. 3 BETHESDA METRO CENTER ? SUITE 630 BETHESDA MD 20814
Business Address (301) 280-1992
Bowles L Thompson (Reporting) CIK: 0001355785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 081083381